DR. ROLF F BARTH, MD
Medical Practice at 10 Ave, Columbus, OH
License number
Ohio 35043588B
Category
Medical Practice
Type
Specialist
Address
Address
W 10Th Ave, Columbus, OH 43210
Phone
(614) 292-2177
(614) 486-1007
(614) 486-1007
Personal information
See more information about ROLF F BARTH at radaris.comName
Address
Phone
2670 Crafton Park, Columbus, OH 43221
2670 Crafton Park, Columbus, OH 43221
2846 Exmoor Rd, Columbus, OH 43221
Organization information
See more information about ROLF F BARTH at bizstanding.comOfc of Rolf F Barth MD
1645 Neil Ave, Columbus, OH 43210
Industry:
Medical Doctor's Office, Nonclassifiable Establishments
Professional information
See more information about ROLF F BARTH at trustoria.com
Dr. Rolf F Barth, Columbus OH - MD (Doctor of Medicine)
Dr. Rolf F Barth, Columbus OH - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
1645 Neil Ave, Columbus 43210
(614) 292-2177 (Phone), (614) 292-7072 (Fax)
(614) 292-2177 (Phone), (614) 292-7072 (Fax)
Certifications:
Anatomic Pathology, 1970
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1645 Neil Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1964
New York-Presbyterian Hospital
Natl Cancer Inst
Karolinska Inst
Columbia University / College of Physicians And Surgeons
Graduated: 1964
New York-Presbyterian Hospital
Natl Cancer Inst
Karolinska Inst
Rolf F Barth, Columbus OH
Rolf F Barth, Columbus OH
Specialties:
Pathologist
Address:
410 W 10Th Ave, Columbus, OH 43210
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
National Institutes of Health-Clinical Center - Residency - Pathology
National Institutes of Health-Clinical Center - Residency - Pathology
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)
Carboranyl Uridines And Their Use In Boron Neutron Capture Therapy
Carboranyl Uridines And Their Use In Boron Neutron Capture Therapy
US Patent:
5466679, Nov 14, 1995
Filed:
Mar 7, 1994
Appl. No.:
8/206750
Inventors:
Albert H. Soloway - Worthington OH
Rolf F. Barth - Columbus OH
Abul K. Anisuzzaman - Westerville OH
Werner Tjarks - Bremen, DE
Iwona M. Wyzlic - Columbus OH
Rolf F. Barth - Columbus OH
Abul K. Anisuzzaman - Westerville OH
Werner Tjarks - Bremen, DE
Iwona M. Wyzlic - Columbus OH
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
A61K 3170, A61K 3322, C07H 1906, C07H 2300
US Classification:
514 50
Abstract:
The invention relates to novel boron-containing nucleosides and amino acids which can utilize the enzymatic systems in tumor cells for incorporating such boron-containing structures into nucleic acids and proteins. Subsequent use of boron neutron capture therapy provides a method for treating tumor cells.
2' And 3' Carboranyl Uridines And Their Diethyl Ether Adducts
2' And 3' Carboranyl Uridines And Their Diethyl Ether Adducts
US Patent:
5171849, Dec 15, 1992
Filed:
Apr 19, 1991
Appl. No.:
7/688121
Inventors:
Albert H. Soloway - Worthington OH
Rolf F. Barth - Columbus OH
Abul K. Anisuzzaman - Columbus OH
Fazlul Alam - Anaheim CA
Werner Tjarks - Columbus OH
Rolf F. Barth - Columbus OH
Abul K. Anisuzzaman - Columbus OH
Fazlul Alam - Anaheim CA
Werner Tjarks - Columbus OH
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
C07H 1900, C07H 2300
US Classification:
536 23
Abstract:
There is disclosed a process for preparing carboranyl uridine nucleoside compounds and their diethyl ether adducts, which exhibit a tenfold increase in boron content over prior art boron containing nucleoside compounds. Said carboranyl uridine nucleoside compounds exhibit enhanced lipophilicity and hydrophilic properties adequate to enable solvation in aqueous media for subsequent incorporation of said compounds in methods for boron neutron capture therapy in mammalian tumor cells.